Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers

Galapagos in Agreement With Abbott for Rheumatoid Arthritis Drug

Galapagos NV said it entered into an agreement with Abbott Laboratories for its rheumatoid arthritis drug and will receive an initial payment of $150 million.

Galapagos would be eligible to receive additional milestone payments from Abbott, potentially amounting to $1 billion, in addition to tiered double-digit royalties on net sales upon commercialization, Galapagos said today in a statement.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.